We are live on ! Find out more
MC

Matisse Capital Portfolio holdings

AUM $234M
1-Year Est. Return 19.72%
This Fund
S&P 500
This Quarter Est. Return
+4.7%
1 Year Est. Return
+19.72%
3 Year Est. Return
+52.07%
5 Year Est. Return
+45.94%
10 Year Est. Return
+148.24%
AUM
$113M
AUM Growth
+$33.7M
Cap. Flow
+$31.3M
Cap. Flow %
27.79%
Top 10 Hldgs %
28.03%
Holding
136
New
52
Increased
20
Reduced
8
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 10.53%
2 Healthcare 8.13%
3 Consumer Discretionary 3.87%
4 Financials 2.74%
5 Real Estate 1.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MHI
126
DELISTED
Pioneer Municipal High Income Fund
MHI
$97.5K 0.09%
11,368
-2,900
-20% -$24.7K
WVE icon
127
Wave Life Sciences
WVE
$1.09B
$85.5K 0.08%
+12,213
New +$56.3K
FSCO
128
FS Credit Opportunities Corp
FSCO
$1B
$72.4K 0.06%
+15,382
New +$74.6K
NG icon
129
NovaGold Resources
NG
$2.56B
$59.8K 0.05%
10,000
VSTM icon
130
Verastem
VSTM
$510M
$14.1K 0.01%
2,917
SIEN
131
DELISTED
Sientra, Inc.
SIEN
$3.21K ﹤0.01%
1,582
DHF
132
BNY Mellon High Yield Strategies Fund
DHF
$171M
-269,838
Closed -$569K
DLY
133
DoubleLine Yield Opportunities Fund
DLY
$682M
-32,028
Closed -$432K
EMO
134
ClearBridge Energy Midstream Opportunity Fund
EMO
$1.03B
-28,992
Closed -$725K
JGH icon
135
Nuveen Global High Income Fund
JGH
$352M
-27,719
Closed -$292K
TEI
136
Templeton Emerging Markets Income Fund
TEI
$314M
-22,992
Closed -$102K

Similar funds

Matisse Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Matisse Capital held 136 positions worth $113M, up 43% from $78.9M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Matisse Capital deployed $31.3M of net new capital in Q4 2022, opening 52 new positions and adding to 20 existing holdings. Its largest new stake was Shockwave Medical, Inc. Common Stock: 10,071 shares worth $2.07M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Tortoise Energy Infrastructure Corp, an estimated $96.5K trimmed.

  • Matisse Capital's largest Q4 2022 buy was Shockwave Medical, Inc. Common Stock: 10,071 shares worth $2.07M.
  • Matisse Capital added most to Ascendis Pharma A/S in Q4 2022, an estimated $593K increase.
  • Matisse Capital's biggest Q4 2022 reduction was Tortoise Energy Infrastructure Corp, cutting an estimated $96.5K.
  • Matisse Capital fully exited ClearBridge Energy Midstream Opportunity Fund in Q4 2022, selling an estimated $725K.
  • Matisse Capital's ten largest holdings make up 28% of its $113M portfolio in Q4 2022.
  • Matisse Capital opened 52 new positions and closed 5 in Q4 2022.
  • Matisse Capital's portfolio value rose 43% quarter-over-quarter to $113M.

Based on Matisse Capital's 13F filing for Q4 2022, filed 20 Jan 2023.